Search

US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance for adults with heart failure independent of left ventricular ejection fractio

US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance for adults with heart failure independent of left ventricular ejection fraction

New type 2 diabetes treatment Jardiance® (empagliflozin) tablets for adults now available in U.S. pharmacies

Telemedicine – the standalone study that became the new normal

Dr Vijay Prabhakar tells us how a remote healing project made him a pandemic pioneer.Read it now!

FDA Advisory Committee Recommends Approval of Tiotropium Respimat® for the Maintenance Treatment of COPD

US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Jardiance shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40% regardless of chronic kidney disease status

Leadership insights about our focus on patient centricity

Read about our patient-centric approach in discovering and developing medicines that transform patients’ lives from the point of view of Keri Yale, our head of patient centricity and engagement

Yamagata

With its location in the Yamagata prefecture (Higashine), this site focuses on the production & packaging of human pharmaceuticals for the Japanese market.

Boehringer Ingelheim bpcia Strength citizen petition

Code-of-Conduct-Boehringer-Ingelheim_0.pdf

Boehringer Ingelheim Invests in You

BIPI Post Marketing Requirements PDF | Boehringer Ingelheim US

Imprint | Boehringer Ingelheim US

Imprint

Carolina Valoyes | Boehringer Ingelheim Careers

Carolina Valoyes talks about her career in the Quality division and what is next for her in the company.

Animal Health | COVID-19 | Boehringer Ingelheim US

Click here to read more on how the COVID-19 pandemic has impacted the daily lives of veterinarians, livestock producers and others.

PDF Download: Heartworm Disease in Dogs | Boehringer Ingelheim US

View our PDF download options on information on heartworm disease in dogs. Find out everything you need to know on prevention, symptoms and treatment.

Albert Paul | Boehringer Ingelheim Careers

Albert Paul speaks about his role in Manufacturing & Supply and and what’s next for him in the future.

Contact Our Team | Human Health | Boehringer Ingelheim US

Find all our contact information here as well as the latest updates on where you can meet our partnering teams virtually or in person.

Fostering Science | Boehringer Ingelheim US

Find out how creating breakthrough medicines to change patients’ lives starts with a commitment to identify the challenges of the future & emerging science.

Partnering-Boehringer-Ingelheim.pdf

First-in-class type 2 diabetes treatment Glyxambi® (empagliflozin/linagliptin) tablets for adults now available in U.S. pharmacies

US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction

2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic

Discover your hidden talent with BI Open – the new platform for data science enthusiasts

Discover your hidden talent with BI Open – the new platform for data science enthusiasts. For more talent insights, visit our Careers Page.

New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers